Related Experiment Video
Updated: May 23, 2025

CRISPR-Cas9-Mediated Genome Editing in the Filamentous Ascomycete Huntiella omanensis
Published on: June 9, 2020
Unravelling fungal genome editing revolution: pathological and biotechnological application aspects
Abdallah M A Hassane1, Marwa Obiedallah2, Javad Karimi3
1Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Assiut Branch, Assiut, 71524, Egypt. abdallahhassane@azhar.edu.eg.
Abstract:
Fungi represent a broad and evolutionarily unique group within the eukaryotic domain, characterized by extensive ecological adaptability and metabolic versatility. Their inherent biological intricacy is evident in the diverse and dynamic relationships they establish with various hosts and environmental niches. Notably, fungi are integral to disease processes and a wide array of biotechnological innovations, highlighting their significance in medical, agricultural, and industrial domains. Recent advances in genetic engineering have revolutionized fungal research, with CRISPR/Cas emerging as the most potent and versatile genome editing platform. This technology enables precise manipulation of fungal genomes, from silencing efflux pump genes in Candida albicans (enhancing antifungal susceptibility) to targeting virulence-associated sirtuins in Aspergillus fumigatus (attenuating pathogenicity). Its applications span gene overexpression, multiplexed mutagenesis, and secondary metabolite induction, proving transformative for disease management and biotechnological innovation. CRISPR/Cas9's advantages-unmatched precision, cost-effectiveness, and therapeutic potential-are tempered by challenges like off-target effects, ethical dilemmas, and regulatory gaps. Integrating nanoparticle delivery systems and multi-omics approaches may overcome technical barriers, but responsible innovation requires addressing these limitations. CRISPR-driven fungal genome editing promises to redefine solutions for drug-resistant infections, sustainable bioproduction, and beyond as the field evolves. In conclusion, genome editing technologies have enhanced our capacity to dissect fungal biology and expanded fungi's practical applications across various scientific and industrial domains. Continued innovation in this field promises to unlock the vast potential of fungal systems further, enabling more profound understanding and transformative biotechnological progress.
Insights
CRISPR/Cas gene editing revolutionizes fungal research, enabling precise genome manipulation for medical and industrial applications. This powerful technology offers solutions for antifungal resistance and sustainable bioproduction.
Area of Science:
- Mycology
- Genetics
- Biotechnology
Background:
- Fungi are evolutionarily unique eukaryotes with diverse ecological roles.
- Fungi are significant in disease, agriculture, and industry.
- Genetic engineering advances fungal research.
Purpose of the Study:
- To highlight the impact of CRISPR/Cas genome editing on fungal research.
- To explore applications in disease management and biotechnology.
- To discuss challenges and future directions.
Main Methods:
- CRISPR/Cas genome editing for precise DNA manipulation.
- Gene silencing in Candida albicans to enhance antifungal susceptibility.
- Targeting virulence genes in Aspergillus fumigatus to reduce pathogenicity.
Main Results:
- CRISPR/Cas enables precise gene editing, overexpression, and mutagenesis in fungi.
- Applications include enhancing antifungal treatments and attenuating fungal pathogens.
- The technology facilitates secondary metabolite induction for biotechnological uses.
Conclusions:
- CRISPR-driven fungal genome editing transforms disease management and bioproduction.
- Challenges include off-target effects and ethical considerations.
- Future innovations promise to unlock further potential in fungal systems.
Related Concept Videos
CRISPR
What is Genetic Engineering?
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Recombinant DNA
Transgenic Plants
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...

